New AI drug discovery startup by Alphabet

In a new company called Isomorphic Labs, Google’s holding Alphabet has launched Isomorphic Labs, an AI company focused on developing new drugs. Demis Hassabis, the CEO of DeepMind, is leading the company. Isomorphic Labs will draw upon the machine learning system developed by DeepMind, which specializes in predicting the folding of proteins. Read more

Related Work